z6com尊龙凯时官网

Products Indication Discovery Pre-clinical Phase 1 Phase 2 Phase 3 BE NDA Pre-clinical Partnership Details
Patented Biopharmaceutical Products
Metabolic
Bogutai® Osteoporosis
Self-R&D
UOS003(oral PTH) Osteoporosis
Self-R&D
Uni-GLP-1(liquid) Type 2 Diabetes
Self-R&D
Uni-GLP-1(liquid) Obesity
Self-R&D
UDS003(oral GLP-1) Type 2 Diabetes
Self-R&D
Ophthalmology
UB101 AMD
UB102 AMD
Wound Care
UB104 Wound Healing
Products Discovery Production Development Formulation Development Marketed Partnership Details
Advanced Skincare Raw Materials
Fibronectin
Beauty peptides
Collagen
Microecological skin-care
Stem cell exosome
Product Indication Information survey Preliminary preparations Research on
prescription
technology		 Quality research Stability study Pharmacology
and Toxicology
Research		 ANDA Marketed Remark Details
High Value Generic Drugs
Endocrinology
Diquafosol sodium eye drops Dry eye
API Manufacturer
Patented Biopharmaceutical Products
Metabolic
Products
Bogutai®
UOS003
(oral PTH)
Uni-
GLP-1
(liquid)
Uni-
GLP-1
(liquid)
UDS003
(oral GLP-1)
Indication Osteoporosis Osteoporosis
Type 2
Diabetes
 Obesity
Type 2
Diabetes
Discovery
Pre-clinical
Phase 1
Phase 2
Phase 3
BE
NDA
Time to
Market
Partnership Self-R&D Self-R&D Self-R&D Self-R&D Self-R&D
Details
Ophthalmology Wound Care
Products
UB101
UB102
UB104
Indication AMD AMD Wound Healing
Discovery
Pre-clinical
Phase 1
Phase 2
Phase 3
BE
NDA
Time to
market
Partnership
Details
Advanced Skincare Raw Materials
Products
Fibron-
ectin
Beauty
peptides
Collagen
Microeco-
logical
skin-care
Stem cell
exosome
Discovery
Production
Development
Formulation
Development
Time to
market
Partnership
Details
High Value Generic Drugs
Ophthalmology
Products
Diquafosol sodium eye drops
Indication Dry eye
Information survey
Preliminary preparations
Research on prescription technology
Quality research
Stability study
Pharmacology and Toxicology Research
ANDA
Time to
market
Partnership API Manufacturer
Details